Changing Scenario in Chronic Ischemic Heart Disease: Therapeutic Implications

American Journal of Cardiology

Volumn 98, Issue 5 SUPPL. 1, 2006, Pages 3-7

  Marzilli, Mario ^a   Affinito, Silvia ^a   Focardi, Marta ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; NITRATE;

ANGINA PECTORIS; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COLLATERAL CIRCULATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE RELAXATION; HEART VENTRICLE; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; LIVER TOXICITY; MORTALITY; NEPHROTOXICITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

CHRONIC DISEASE; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 33747365800     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.002     Document Type: Article

References (31)

1. Management of stable angina pectoris. recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 18 (1997) 394-413
2. American Heart Association. Heart Disease and Stroke Statistics. 2003 Update (2002), American Heart Association, Dallas
3. Gibbons R.J., Chatterjee K., Daley J., Douglas J.S., Fihn S.D., Gardin J.M., Grunwald M.A., Levy D., Lytle B.W., O'Rourke R.A., et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 33 (1999) 2092-2197
4. Pepine C.J., Abrams J., Marks R.G., Morris J.J., Scheidt S.S., Handberg E., and TIDES Investigators. Characteristics of a contemporary population with angina pectoris. Am J Cardiol 74 (1994) 226-231
5. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. a multicenter randomized trial. JAMA 277 (1997) 715-721
6. Henderson R.A., Pocock S.J., Clayton T.C., Knight R., Fox K.A.A., Julian D.G., Chamberlain D.A., and Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial. coronary angioplasty versus medical treatment. J Am Coll Cardiol 42 (2003) 1161-1170
7. Bucher H.C., Hengstler P., Schindler C., and Guyatt G.H. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease. meta-analysis of randomised controlled trials. BMJ 321 (2000) 73-77
8. Hemingway H., Crook A.M., Feder G., Banerjee S., Dawson J.R., Magee P., Philpott S., Sanders J., Wood A., and Timmis A.D. Underuse of revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med 344 (2001) 645-654
9. Serruys P.W., Unger F., Sousa J.E., Jatene A., Bonnier H.J., Schonberger J.P., Buller N., Bonser R., van den Brand M.J., van Herwerden L.A., Morel M.A., van Hout B.A., and Arterial Revascularization Therapies Study Group. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124
10. Blumenthal R.S., Cohn G., and Schulman S.P. Medical therapy versus coronary angioplasty in stable coronary artery disease. a critical review of the literature. J Am Coll Cardiol 36 (2000) 668-673
11. Sambuceti G., Marzilli M., Fedele S., Marini C., and L'Abbate A. Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease. Circulation 103 (2001) 2352-2360
12. Marzilli M., Sambuceti G., Testa R., and Fedele S. Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina. J Am Coll Cardiol 40 (2002) 2102-2109
13. National Center for Health Statistics. Current Estimates from the National Health Interview Survey (1989), US Government Printing Office, Washington, DC Vital and Health Statistics series 10
14. Phillips G.B., Pinkernell B.H., and Jing T.Y. Are major risk factors for myocardial infarction predictors of degree of coronary artery disease in men?. Metabolism 53 (2004) 324-329
15. Havranek E., Masoudi F., Westfal K.A., Wolfe P., Ordin D.L., and Krumholz H.M. Spectrum of heart failure in older patients. results from the National Heart Failure Project. Am Heart J 143 (2002) 412-417
16. Kass D.A. Age-related changes in venticular-arterial coupling. pathophysiologic implications. Heart Fail Rev 7 (2002) 51-62
17. Rahimtoola S.H. A perspective on the three large multicenter randomised clinical trials of coronary bypass surgery for chronic stable angina. Circulation 76 (1985) V123-V125
18. Gersh B.J. Coronary revascularization for angina pectoris in the elderly. Rev Cardiovasc Med 4 (2003) 55-58
19. Greenblatt D.J., Sellers E.M., and Shader R.I. Drug disposition in old age. N Engl J Med 306 (1982) 1061-1088
20. Vestal R.E. Drug use in the elderly? A review of problems and special considerations. Drugs 16 (1978) 358-382
21. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes. estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
22. National Diabetes Education Program. E-Newsletter. May 2004. http://ndep.nih.gov/new/NewsNotes/NDEPNewsNotes.htm. Accessed December 2005.
23. Centers for Disease Control and Prevention (CDC). Major cardiovascular disease (CVD) during 1997-1999 and major CVD hospital discharge rates in 1997 among women with diabetes. United States. Morb Mortal Wkly Rep 50 (2001) 948-954
24. Moreno P.R., Murcia A.M., Palacios I.F., Leon M.N., Bernardi V.H., Fuster V., and Fallon J.T. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 102 (2000) 2142-2180
25. Falk E. Coronary plaque disruption. Circulation 92 (1995) 657-671
26. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96 (1997) 1761-1769
27. Elezi S., Kastrati A., Pache J., Wehinger A., Hadamitzky M., Dirschinger J., Neumann F.J., and Schömig A. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32 (1998) 1866-1873
28. Roger V.L., Weston S.A., Redfield M.M., Hellermann-Homan J.P., Killian J., Yawn B.P., and Jacobsen S.J. Trends in heart failure incidence and survival in a community-based population. JAMA 292 (2004) 344-350
29. Stanley W.C. Partial inhibition of cardiac fatty acid oxidation for the treatment of chronic stable angina. Expert Opin Investig Drugs 11 (2002) 615-629
30. Stanley W.C., and Marzilli M. Metabolic therapy in the treatment of ischemic heart disease. the pharmacology of trimetazidine. Fundam Clin Pharmacol 17 (2003) 133-145
31. Oliver M.F., and Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343 (1994) 155-158